Clinical trial endpoint development process

• US 8,380,531 B2
• Filed: 07/24/2009
• Issued: 02/19/2013
• Est. Priority Date: 07/25/2008
• Status: Active Grant

• Current Assignee: eResearchTechnology, Inc. (Explorer Holdings, Inc.)
• Original Assignee: Invivodata Incorporated (Explorer Holdings, Inc.)
• Inventors: Paty, Jean, Shields, Alan, Gwaltney, Chad, Tiplady, Brian
• Primary Examiner(s): Gilligan, Luke
• Application Number:
  US12/509,318
• Publication Number:
  US 20100023346A1
• Time in Patent Office: 1,306 Days
• Field of Search: 705 2- 3, 600/300
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/00 Administration; Management
• CPC Class Codes: G06Q 30/0203 Market surveys; Market polls
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16Z 99/00 Subject matter not provided for in other main groups of this subclass

Abstract

A system for developing and producing clinical endpoints based on patient reported outcome data utilizing algorithms to generate decision rules to evaluate patient reported outcome type questionnaire is provided. The questionnaires can include health-related quality of life questionnaires and can predict the reliability of endpoints in supporting one or more medical labeling claims.

Claims

1. A method of clinical trial endpoint development comprising:

a) administering one or more questions to a subject who is administered a medical product or a placebo, wherein said one or more questions are administered to said subject by a portable electronic device, wherein said device records data about said subject'"'"'s response to said one or more questions, wherein said one or more questions comprise at least one health-related quality of life (HRQOL) question;

b) analyzing said data, wherein said analyzing comprises a statistical analysis of responses to said at least one HRQOL question;

c) developing at least one validated HRQOL question based on said analysis, wherein said developing comprises

i) determining whether said at least one HRQOL question is an unqualified HRQOL question or a validated HRQOL question based on a capacity of said at least one HRQOL question to serve as an evaluative indicator,

ii) for said unqualified HRQOL question, revising and/or recreating said unqualified HRQOL question, and repeating steps a) and b); and

retaining said revised and/or recreated unqualified HRQOL question as a validated HRQOL question based on a capacity of said revised and/or recreated unqualified HRQOL question to serve as an evaluative indicator;

d) collecting responses from more than one subject administered said validated HRQOL question;

e) developing one or more clinical trial endpoints based on said responses to said validated HRQOL question; and

f) assessing a label claim of said medical product tested in a clinical trial comprising said one or more clinical trial endpoints.

2. The method of claim 1, wherein said step a) of administering one or more questions to a subject is part of a pilot trial.

3. The method of claim 1, wherein said analyzing said data is performed on said portable electronic device.

4. The method of claim 1, wherein said analyzing said data comprises sending said data to a data analysis system, wherein said data is analyzed.

5. The method of claim 4, wherein said data is sent to said data analysis system by a wireless connection or wired connection.

6. The method of claim 1, wherein said clinical trial tests said medical product or a placebo on a human subject.

7. The method of claim 1, wherein said analyzing comprises psychometric validation of said data.

8. The method of claim 1, wherein said administering comprises prompting said subject to answer said one or more questions.

9. The method of claim 8, wherein said prompting occurs at a pre-scheduled time or a random time.

10. The method of claim 1, wherein said data comprises information on a time said subject responds to said one or more questions, a date said subject responds to said one or more questions, or a location of said portable electronic device when said subject responds to said one or more questions.

11. The method of claim 1, wherein said analyzing comprises a statistical hypothesis test.

12. The method of claim 11, wherein said statistical hypothesis test is a t-test or a probability value test.

13. The method of claim 1, wherein said data comprises patient-reported outcome (PRO) data or metadata.

14. The method of claim 1, wherein said label claim is an efficacy claim, a safety claim, a toxicity claim, a treatment claim, a health claim, a nutritional claim or a structure/function claim.

15. The method of claim 1, wherein said label claim is reviewed by a regulatory agency.

16. The method of claim 15, wherein said regulatory agency is the United States Food and Drug Administration.

17. The method of claim 1, wherein said medical product is a drug, a biologic, a medical device, a dietary supplement or a cosmetic that is intended to have a human or veterinary use.

18. A computer program product comprising a non-transitory computer readable medium having computer program logic encoded thereon for enabling a processor to develop a clinical trial endpoint comprising:

a) a receiving procedure that enables a processor to receive data from a portable electronic device, wherein said data comprises a response to one or more questions responded to by a subject who is administered a medical product or a placebo, wherein said one or more questions are administered to said subject by said portable electronic device, wherein said one or more questions comprise at least one health-related quality of life (HRQOL) question;

b) an analyzing procedure to analyze said data, wherein said analyzing comprises a statistical analysis of responses to said at least one HRQOL question;

c) a developing procedure to develop at least one validated HRQOL question, wherein said developing comprises

i) determining whether said at least one HRQOL question is an unqualified HRQOL question or a validated HRQOL question based on a capacity of said at least one HRQOL question to serve as an evaluative indicator,

ii) for said unqualified HRQOL question, revising and/or recreating said unqualified HRQOL question and repeating a) and b); and

retaining said revised and/or recreated unqualified HRQOL question as a validated HRQOL question based on a capacity of said revised and/or recreated unqualified HRQOL question to serve as an evaluative indicator;

d) a collecting procedure for collecting responses from more than one subject administered said validated HRQOL question;

e) an output procedure to provide one or more clinical trial endpoints based on responses to said validated HRQOL question; and

f) an assessing procedure for assessing a label claim of said medical product tested in a clinical trial comprising said one or more clinical trial endpoints.

19. The computer program product of claim 18, wherein said data comprises PRO data or metadata.

20. The computer program product of claim 18, wherein said label claim is an efficacy claim, a safety claim, a toxicity claim, a treatment claim, a health claim, a nutritional claim or a structure/function claim.

21. The computer program product of claim 18, where said label claim is reviewed by a regulatory agency.

22. The computer program product of claim 21, wherein said regulatory agency is the United States Food and Drug Administration.

23. The computer program product of claim 18, wherein said medical product is a drug, a biologic, a medical device, a dietary supplement or a cosmetic that is intended to have a human or veterinary use.

24. The computer program product of claim 18, wherein said administering one or more questions to a subject is part of a pilot trial.

25. The computer program product of claim 18, wherein said analyzing said data is performed on said portable electronic device.

26. The computer program product of claim 18, wherein said analyzing said data comprises sending said data to a data analysis system, wherein said data is analyzed.

27. The computer program product of claim 26, wherein said data is sent to said data analysis system by a wireless connection or wired connection.

28. The computer program product of claim 18, wherein said clinical trial tests said medical product or a placebo on a human subject.

29. The computer program product of claim 18, wherein said analyzing comprises psychometric validation of said data.

30. The computer program product of claim 18, wherein said administering comprises prompting said subject to answer said one or more questions.

31. The computer program product of claim 30, wherein said prompting occurs at a pre-scheduled time or a random time.

32. The computer program product of claim 18, wherein said data comprises information on a time said subject responds to said one or more questions, a date said subject responds to said one or more questions, or a location of said portable electronic device when said subject responds to said one or more questions.

33. The computer program product of claim 18, wherein said analyzing comprises a statistical hypothesis test.

34. The computer program product of claim 33, wherein said statistical hypothesis test is a t-test or a probability value test.

35. A computer system for clinical trial endpoint development comprising a non-transitory computer readable medium having computer program logic encoded thereon, wherein said computer program logic comprises instructions, which comprise:

a) input instructions for receiving data from a portable electronic device, wherein said data comprises a response to one or more questions responded to by a subject who is administered a medical product or a placebo, wherein said one or more questions are administered to said subject by said portable electronic device, wherein said one or more questions comprise at least one health-related quality of life (HRQOL) question;

b) analysis instructions for analyzing said data, wherein said analyzing comprises a statistical analysis of responses to said at least one HRQOL question;

c) developing instructions for developing at least one validated HRQOL question, wherein said developing comprises

i) determining whether said at least one HRQOL question is an unqualified HRQOL question or a validated HRQOL question based on a capacity of said at least one HRQOL question to serve as an evaluative indicator,

ii) for said unqualified HRQOL question, revising and/or recreating said unqualified HRQOL question and repeating execution of a) and b); and

retaining said revised and/or recreated unqualified HRQOL question as a validated HRQOL question based on a capacity of said revised and/or recreated unqualified HRQOL question to serve as an evaluative indicator;

d) collecting instructions for collecting responses from more than one subject administered said validated HRQOL question;

e) output instructions for providing one or more clinical trial endpoints based on said responses to said validated HRQOL question; and

f) assessing instructions for assessing a label claim of said medical product tested in a clinical trial comprising said one or more clinical trial endpoints.

36. The computer system of claim 35, wherein said data comprises PRO data or metadata.

37. The computer system of claim 35, further comprising instructions to send information to said portable electronic device, wherein said computer system is remote from said portable electronic device.

38. The computer system of claim 37, wherein said information comprises one or more questions.

39. The computer system of claim 35, wherein said label claim is an efficacy claim, a safety claim, a toxicity claim, a treatment claim, a health claim, a nutritional claim or a structure/function claim.

40. The computer system of claim 35, wherein said label claim is reviewed by a regulatory agency.

41. The computer system of claim 40, wherein said regulatory agency is the United States Food and Drug Administration.

42. The computer system of claim 35, wherein said medical product is a drug, a biologic, a medical device, a dietary supplement or a cosmetic that is intended to have a human or veterinary use.

43. The computer system of claim 35, wherein said administering one or more questions to a subject is part of a pilot trial.

44. The computer system of claim 35, wherein said analyzing said data is performed on said portable electronic device.

45. The computer system of claim 35, wherein said analyzing said data comprises sending said data to a data analysis system, wherein said data is analyzed.

46. The computer system of claim 45, wherein said data is sent to said data analysis system by a wireless connection or wired connection.

47. The computer system of claim 35, wherein said clinical trial tests said medical product or a placebo on a human subject.

48. The computer system of claim 35, wherein said analyzing comprises psychometric validation of said data.

49. The computer system of claim 35, wherein said administering comprises prompting said subject to answer said one or more questions.

50. The computer system of claim 49, wherein said prompting occurs at a pre-scheduled time or a random time.

51. The computer system of claim 35, wherein said data comprises information on a time said subject responds to said one or more questions, a date said subject responds to said one or more questions, or a location of said portable electronic device when said subject responds to said one or more questions.

52. The computer system of claim 35, wherein said analyzing comprises a statistical hypothesis test.

53. The computer system of claim 52, wherein said statistical hypothesis test is a t-test or a probability value test.